BioSpace News Archive

Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today announced that it will host a virtual R&D webinar for analysts and investors on Wednesday, November 18, 2020 at 4:30 p.m. EST.

ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its third quarter 2020 financial results on Tuesday, November 10, 2020, before the U.S. financial markets open.

Sobi™ will present data at the 62nd Annual Meeting of the American Society of Hematology taking place taking place as a virtual meeting from 5-8 December.

Economic activity in the hospital subsector grew in October for the fifth consecutive month, say the nation’s hospital supply executives in the latest Hospital ISM® Report On Business®.

The Miami Dade County Board of County Commissioners awarded $3,000,000 in Coronavirus Relief Funds to St. Thomas University’s Center for Pandemic, Disaster and Quarantine Research.

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), today announced additional details on and presented the results from the proof of concept Phase 2 controlled trial evaluating the safety, tolerability, and efficacy of ANAVEX®2-73

OncLive® is pleased to announce that yesterday it honored 15 remarkable cancer care pioneers during the 8th Annual Giants of Cancer Care® Awards Ceremony.

Mesa Biotech, developers of an affordable, easy to use, handheld testing platform for infectious disease diagnosis, today announced it has been awarded a contract up to $13 million from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the US Department of Health and Human Services (HHS)

The Lupus Research Alliance (LRA), the largest private funder of lupus research in the world, is proud to announce important results of 21 studies supported by the LRA to be presented at ACR Convergence 2020 – this year’s virtual annual meeting of the American College of Rheumatology.

Twelve-Month Results Presented Today in Late-Breaking Trials Session at Vascular Interventional Advances (VIVA) Conference